Glaucoma screening in a high-risk population

Journal of Glaucoma

Volumn 15, Issue 6, 2006, Pages 534-540

  Vistamehr, Setareh ^a   Shelsta, Heather N ^a   Palmisano, Philip C ^a   Filardo, Giovanni ^a,b,c   Bashford, Kent ^a   Chaudhri, Kamran ^a   Forster, Susan H ^a   Shafranov, George ^a   Bruce Shields, M ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SOUTHERN METHODIST UNIVERSITY   (United States)

^c BAYLOR HEALTH CARE SYSTEM   (United States)

Author keywords

Frequency Doubling Technology (FDT); Glaucoma; Screening

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FAMILY HISTORY; FEMALE; FOLLOW UP; GLAUCOMA; GONIOSCOPY; HIGH RISK POPULATION; HUMAN; INTRAOCULAR PRESSURE; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; OCULOPLETHYSMOGRAPHY; OPEN ANGLE GLAUCOMA; OPHTHALMOSCOPY; PACHOMETRY; PRIORITY JOURNAL; QUESTIONNAIRE; RELATIVE; SENSITIVITY AND SPECIFICITY; VISUAL ACUITY; VISUAL FIELD;

ADULT; AFRICAN AMERICANS; AGED; AGED, 80 AND OVER; CHRONIC DISEASE; CONNECTICUT; FEMALE; GLAUCOMA, OPEN-ANGLE; GONIOSCOPY; HUMANS; INTRAOCULAR PRESSURE; MALE; MASS SCREENING; MIDDLE AGED; OPTIC DISK; OPTIC NERVE DISEASES; QUESTIONNAIRES; RISK FACTORS; SENSITIVITY AND SPECIFICITY; TONOMETRY, OCULAR; VISION DISORDERS; VISUAL ACUITY; VISUAL FIELDS;

EID: 33751062048     PISSN: 10570829     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ijg.0000212282.88347.c9     Document Type: Article

References (12)

1. Quigley HA. The number of people with glaucoma worldwide. Br J Ophthalmol. 1996;80:389-393.
2. Palmisano P, Hynes M, Mueller L. Glaucoma and race: a case for screening in Connecticut. Connecticut Med. 2000;64:75-78.
3. Merritt JC. Glaucoma blindness in African Americans: have 55 years of therapies, technologies, and talent altered blindness rates? J National Med Assoc. 1995;88:809-819.
4. Sponsel WE. Tonometry in question: can visual screening tests play a more decisive role in glaucoma diagnosis and management? Surv Ophthalmol. 1989;33(suppl):291-300.
5. Mundorf TK, Zimmerman TJ, Nardin GF, et al. Automated perimetry, tonometry, and questionnaire in glaucoma screening. Am J Ophthalmol. 1989;108:505-508.
6. Sommer A, Katz J, Quigley HA, et al. Clinically detectable nerve fiber atrophy precedes the onset of glaucomatous field loss. Arch Ophthalmol. 1991;109:77-83.
7. Johnson CA, Samuels SJ. Screening for glaucomatous visual field loss with frequency-doubling perimetry. Invest Ophthalmol Vis Sci. 1997;38:413-425.
8. Quigley HA. Identification of glaucoma-related visual field abnormality with the screening protocol of frequency doubling technology. Am J Ophthalmol. 1998;125:819-829.
9. Yamada N, Chen PP, Mills RP, et al. Screening for glaucoma with frequency-doubling technology and Damato Campimetry. Arch Ophthalmol. 1999;117:1479-1484.
10. Johnson CA, Wall M, Fingeret M, et al. A Primer for Frequency Doubling Technology. Welch Allyn:Manual for FDT by Humphrey Systems; 1998.
11. Mansberger SL, Johnson CA, Cioffi GA, et al. Predictive value of frequency doubling technology perimetry for detecting glaucoma in a developing country. J Glaucoma. 2005;14:128-134.
12. Quigley HA. Current and future approaches to glaucoma screening. J Glaucoma. 1998;7:210-220.